Skip to main content
    I

    Immix Biopharma Inc (IMMX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.48
    -0.36 (-4.59%)

    Market Cap: $657.09M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Immix Biopharma Inc (IMMX) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Immix Biopharma (IMMX) is expected to report earnings on Mar 23, 2027. In the quarter ended Sep 30, 2026, Immix Biopharma reported EPS of -$0.19, below the -$0.18 estimate. It beat the EPS estimate in 2 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    24%(4/17)
    Avg Surprise
    -13.09%

    Upcoming Estimates

    Reports Mar 23, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.21
    Range-$0.25 - -$0.18
    9 analysts
    Revenue Consensus
    N/A
    RangeN/A
    7 analysts

    Next Report

    IMMX has an expected report date of Mar 23, 2027.

    Earnings History

    Of the 17 quarters below that had an estimate, IMMX beat 4, missed 10 and matched 3. The widest gap in the table came in the quarter ended Dec 31, 2025, when EPS landed 86.67% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.19-$0.18-$0.21 - -$0.17-5.56%MissN/A71 up, 0 downNov 12, 2026
    Jun 30, 2026-$0.18-$0.17-$0.22 - -$0.15-5.88%MissN/A73 up, 1 downAug 7, 2026
    Mar 31, 2026-$0.18-$0.21-$0.25 - -$0.17+14.29%BeatN/A40 up, 1 downMay 7, 2026
    Dec 31, 2025-$0.28-$0.15-$0.21 - -$0.13-86.67%MissN/A31 up, 0 downMar 25, 2026
    Sep 30, 2025-$0.24-$0.19-$0.19 - -$0.19-26.32%MissN/A10 up, 1 downNov 7, 2025
    Jun 30, 2025-$0.22-$0.16-$0.16 - -$0.16-37.50%MissN/A11 up, 0 downAug 8, 2025
    Mar 31, 2025-$0.15-$0.23-$0.23 - -$0.23+34.78%BeatN/A10 up, 1 downMay 8, 2025
    Dec 31, 2024-$0.25-$0.25-$0.25 - -$0.250.00%In lineN/A10 up, 1 downMar 24, 2025
    Sep 30, 2024-$0.24-$0.16-$0.16 - -$0.16-50.00%MissN/A10 up, 0 downNov 12, 2024
    Jun 30, 2024-$0.15-$0.21-$0.21 - -$0.21+28.57%BeatN/A10 up, 0 downAug 12, 2024
    Mar 31, 2024-$0.22-$0.23N/A+4.35%BeatN/AN/A0 up, 0 downMay 9, 2024
    Dec 31, 2023-$0.23-$0.23N/A0.00%In lineN/AN/A0 up, 0 downMar 29, 2024
    Sep 30, 2023-$0.23-$0.23-$0.23 - -$0.230.00%In lineN/A10 up, 0 downNov 9, 2023
    Jun 30, 2023-$0.24-$0.17-$0.17 - -$0.17-41.18%MissN/A10 up, 0 downAug 11, 2023
    Mar 31, 2023-$0.18-$0.14-$0.14 - -$0.14-28.57%MissN/A10 up, 0 downMay 12, 2023
    Dec 31, 2022-$0.27-$0.22N/A-22.73%MissN/A10 up, 1 downMar 27, 2023
    Sep 30, 2022-$0.11-$0.11N/A-0.18%MissN/AN/AN/ANov 9, 2022
    Jun 30, 2022-$0.11N/AN/AN/AN/AN/AN/AN/AAug 12, 2022
    Mar 31, 2022-$0.10N/AN/AN/AN/AN/AN/AN/AMay 13, 2022
    Dec 31, 2021-$3.16N/AN/AN/AN/AN/AN/AN/AMar 28, 2022
    Sep 30, 2021-$0.02N/AN/AN/AN/AN/AN/AN/ADec 17, 2021
    Jun 30, 2021-$0.16N/AN/AN/AN/AN/AN/AN/ASep 17, 2021
    Mar 31, 2021-$0.18N/AN/AN/AN/AN/AN/AN/AJun 29, 2021
    Dec 31, 2020-$0.18N/AN/AN/AN/AN/AN/AN/AMar 31, 2021
    Jun 30, 2020-$0.03N/AN/AN/AN/AN/AN/AN/ASep 30, 2020
    Mar 31, 2020-$0.04N/AN/AN/AN/AN/AN/AN/AJun 29, 2020
    Dec 31, 2019-$0.04N/AN/AN/AN/AN/AN/AN/AMar 30, 2020
    Last 27 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.89, after -$0.86 the year before. It was -$0.04 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.89N/A
    Dec 31, 2024-$0.86N/A
    Dec 31, 2023-$0.88N/A
    Dec 31, 2022-$0.59N/A
    Dec 31, 2021-$3.52N/A
    Dec 31, 2020-$0.26N/A
    Dec 31, 2019-$0.04N/A

    Frequently Asked Questions About IMMX

    When is Immix Biopharma's next earnings date?

    Immix Biopharma's next earnings report is expected for Mar 23, 2027.

    Did IMMX beat earnings estimates last quarter?

    No. Immix Biopharma reported EPS of -$0.19 for the quarter ended Sep 30, 2026, below the -$0.18 estimate by 5.56%.

    What EPS do analysts expect from IMMX next quarter?

    The consensus EPS estimate for Immix Biopharma for the quarter ending Dec 31, 2026 is -$0.21 from 9 analysts, with estimates from -$0.25 to -$0.18.

    How often does IMMX beat earnings estimates?

    Immix Biopharma beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -14.11%.